Format
Sort by
Items per page

Send to

Choose Destination

Links from Books

Items: 1 to 20 of 60

1.

Molecular gene expression profiling to predict the tissue of origin and direct site-specific therapy in patients with carcinoma of unknown primary site: a prospective trial of the Sarah Cannon research institute.

Hainsworth JD, Rubin MS, Spigel DR, Boccia RV, Raby S, Quinn R, Greco FA.

J Clin Oncol. 2013 Jan 10;31(2):217-23. doi: 10.1200/JCO.2012.43.3755. Epub 2012 Oct 1.

PMID:
23032625
2.

Cervical lymph node metastases from unknown primary cancer: a single-institution experience with intensity-modulated radiotherapy.

Villeneuve H, Després P, Fortin B, Filion E, Donath D, Soulières D, Guertin L, Ayad T, Christopoulos A, Nguyen-Tan PF.

Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):1866-71. doi: 10.1016/j.ijrobp.2011.02.031. Epub 2011 Apr 15.

PMID:
21497452
3.

Efficacy and toxicity of chemoradiotherapy using intensity-modulated radiotherapy for unknown primary of head and neck.

Sher DJ, Balboni TA, Haddad RI, Norris CM Jr, Posner MR, Wirth LJ, Goguen LA, Annino D, Tishler RB.

Int J Radiat Oncol Biol Phys. 2011 Aug 1;80(5):1405-11. doi: 10.1016/j.ijrobp.2010.04.029. Epub 2010 Dec 20.

PMID:
21177045
4.

Molecular profiling of carcinoma of unknown primary and correlation with clinical evaluation.

Varadhachary GR, Talantov D, Raber MN, Meng C, Hess KR, Jatkoe T, Lenzi R, Spigel DR, Wang Y, Greco FA, Abbruzzese JL, Hainsworth JD.

J Clin Oncol. 2008 Sep 20;26(27):4442-8. doi: 10.1200/JCO.2007.14.4378.

PMID:
18802157
5.

Gene expression profiling to identify the histogenetic origin of metastatic adenocarcinomas of unknown primary.

Horlings HM, van Laar RK, Kerst JM, Helgason HH, Wesseling J, van der Hoeven JJ, Warmoes MO, Floore A, Witteveen A, Lahti-Domenici J, Glas AM, Van't Veer LJ, de Jong D.

J Clin Oncol. 2008 Sep 20;26(27):4435-41. doi: 10.1200/JCO.2007.14.6969.

PMID:
18802156
6.

Intensity-modulated radiotherapy for cervical lymph node metastases from unknown primary cancer.

Madani I, Vakaet L, Bonte K, Boterberg T, De Neve W.

Int J Radiat Oncol Biol Phys. 2008 Jul 15;71(4):1158-66. doi: 10.1016/j.ijrobp.2007.11.059. Epub 2008 Feb 6.

PMID:
18258383
7.

Role of radiotherapy in the treatment of cervical lymph node metastases from an unknown primary site: retrospective analysis of 113 patients.

Beldì D, Jereczek-Fossa BA, D'Onofrio A, Gambaro G, Fiore MR, Pia F, Chiesa F, Orecchia R, Krengli M.

Int J Radiat Oncol Biol Phys. 2007 Nov 15;69(4):1051-8. Epub 2007 Aug 22.

PMID:
17716824
8.

Diagnostic and therapeutic management of cancer of an unknown primary.

Pavlidis N, Briasoulis E, Hainsworth J, Greco FA.

Eur J Cancer. 2003 Sep;39(14):1990-2005. Review.

PMID:
12957453
9.

Localised disease in cancer of unknown primary (CUP): the value of positron emission tomography (PET) for individual therapeutic management.

Rades D, Kühnel G, Wildfang I, Börner AR, Schmoll HJ, Knapp W.

Ann Oncol. 2001 Nov;12(11):1605-9.

PMID:
11822762
10.

Carcinoma of unknown primary site.

Greco FA, Burris HA 3rd, Erland JB, Gray JR, Kalman LA, Schreeder MT, Hainsworth JD.

Cancer. 2000 Dec 15;89(12):2655-60.

PMID:
11135228
11.

Classification and regression tree analysis of 1000 consecutive patients with unknown primary carcinoma.

Hess KR, Abbruzzese MC, Lenzi R, Raber MN, Abbruzzese JL.

Clin Cancer Res. 1999 Nov;5(11):3403-10.

12.

18F-FDG whole body positron emission tomography (PET) in patients with unknown primary tumours (UPT).

Lassen U, Daugaard G, Eigtved A, Damgaard K, Friberg L.

Eur J Cancer. 1999 Jul;35(7):1076-82.

PMID:
10533451
13.

Cancer of Unknown Primary Origin.

Briasoulis E, Pavlidis N.

Oncologist. 1997;2(3):142-152.

14.

Unknown primary head and neck squamous cell carcinoma: molecular identification of the site of origin.

Califano J, Westra WH, Koch W, Meininger G, Reed A, Yip L, Boyle JO, Lonardo F, Sidransky D.

J Natl Cancer Inst. 1999 Apr 7;91(7):599-604.

PMID:
10203278
15.

Poorly differentiated neuroendocrine carcinoma of unknown primary tumor site.

Garrow GC, Greco FA, Hainsworth JD.

Semin Oncol. 1993 Jun;20(3):287-91. Review. No abstract available.

PMID:
8503025
16.

Use of biological markers in the diagnosis of cancers of unknown primary tumor.

Ruddon RW, Norton SE.

Semin Oncol. 1993 Jun;20(3):251-60. Review. No abstract available.

PMID:
8503021
17.

Pathological evaluation of neoplasms with unknown primary tumor site.

Mackay B, Ordonez NG.

Semin Oncol. 1993 Jun;20(3):206-28. Review. No abstract available.

PMID:
8503017
18.

Treatment of patients with cancer of an unknown primary site.

Hainsworth JD, Greco FA.

N Engl J Med. 1993 Jul 22;329(4):257-63. Review. No abstract available.

PMID:
8316270
19.

Clinical relevance of the i(12p) marker chromosome in germ cell tumors.

Bosl GJ, Ilson DH, Rodriguez E, Motzer RJ, Reuter VE, Chaganti RS.

J Natl Cancer Inst. 1994 Mar 2;86(5):349-55.

PMID:
8308927
20.

Unknown primary carcinoma: natural history and prognostic factors in 657 consecutive patients.

Abbruzzese JL, Abbruzzese MC, Hess KR, Raber MN, Lenzi R, Frost P.

J Clin Oncol. 1994 Jun;12(6):1272-80.

PMID:
8201389

Supplemental Content

Support Center